Blog
RSS FeedPosted by Michael Wonder on 20 Oct 2022
Ireland’s cancer survival rates lag behind other EU countries with access to new drugs ‘limited’
20 October 2022 - Patient access to newer cancer medicines is limited and comes later in Ireland compared to other ...
Posted by Michael Wonder on 01 Aug 2022
HSE weighs up impact of obesity drug that costs 250 Euros a month
31 July 2022 - Health authorities are evaluating whether a game changing new obesity drug should be used in Ireland ...
Posted by Michael Wonder on 08 Jun 2022
Irish parents ‘breaking down and crying’ as children denied life changing cystic fibrosis medication
8 June 2022 - Sarah O’Keeffe found out that her son would not be getting the medication that would improve his ...
Posted by Michael Wonder on 02 Jun 2022
Thousands sign petition demanding 35 kids with cystic fibrosis be given life-saving drug Kaftrio
2 June 2022 - 'The lives of our children are at stake here, and we need to have this drug'. ...
Posted by Michael Wonder on 25 May 2022
'Intensive work' ongoing to give 35 children with cystic fibrosis access to life-changing drug
24 May 2022 - Health Minister Stephen Donnelly has said he wants to see the 35 children with cystic fibrosis ...
Posted by Michael Wonder on 16 May 2022
Spravato approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder
16 May 2022 - Janssen has announced that Spravato (esketamine) nasal spray has been granted reimbursement in Ireland for the ...
Posted by Michael Wonder on 26 Apr 2022
Just one in five new cancer treatments available to Irish patients
26 April 2022 - Delays in reimbursing new treatments may affect course of illnesses, study says. ...
Posted by Michael Wonder on 13 Apr 2022
Irish cancer patients wait four months longer for access to new drugs than rest of Europe
11 April 2022 - Cancer patients in Ireland are waiting on average four months longer than people with the disease ...
Posted by Michael Wonder on 11 Nov 2021
HSE approves reimbursement of Ajovy (fremanezumab) in migraine
11 November 2021 - Teva Pharmaceuticals Ireland has announced the approval of Ajovy (fremanezumab) 225 mg pre-filled syringe for prescription ...
Posted by Michael Wonder on 11 Nov 2021
Tremfya (guselkumab) approved for reimbursement in Ireland for active psoriatic arthritis
11 November 2021 - The Janssen Pharmaceutical Companies of Johnson & Johnson have announced that Tremfya (guselkumab), a first-in-class treatment ...
Posted by Michael Wonder on 12 Jul 2021
Minister for Health announces HSE approval to reimburse patisiran (Onpattro)
12 July 2021 - The Minister for Health, Stephen Donnelly TD is pleased to announce that the drug patisiran (Onpattro) ...
Posted by Michael Wonder on 31 May 2021
State slower to ‘adopt new drugs’ than most of western Europe
31 May 2021 - Medicines regularly not worth approving at asking price. ...
Posted by Michael Wonder on 27 May 2021
Ireland an outlier without access to new cell and gene therapy, report says
27 May 2021 - Upfront costs high but treatments may cut long-term expense and boost patient results. ...
Posted by Michael Wonder on 17 Aug 2020
Irish pharmacists lobby for biosimilar substitution
17 August 2020 - Pharmacists in Ireland say the country is losing out on hundreds of millions of dollars in savings ...
Posted by Michael Wonder on 14 Jun 2020
Sacubitril/valsartan (Entresto) utilisation and prescribing patterns in the context of a reimbursement application system
12 June 2020 - The aim of this study was to evaluate the utilisation of Entresto in Ireland and compare patient ...